Sfoglia per Autore
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients
2020 Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L.
Impressive continuous complete response after mogamulizumab in a heavily pretreated Sézary syndrome patient
2020 Lolli G.; Casadei B.; Argnani L.; Nanni L.; Cavo M.; Zinzani P.L.
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study
2020 Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi, Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma
2020 Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Cavo M.; Zinzani P.L.
Elderly Non-GCB Diffuse Large B-Cell Lymphoma Patient Responding to Lenalidomide after Epicardial Relapse: A Case Report
2020 Gentilini M.; Casadei B.; Broccoli A.; Argnani L.; Cavo M.; Zinzani P.L.
Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report
2020 Marangon M.; Casadei B.; Broccoli A.; Argnani L.; Cavo M.; Zinzani P.L.
Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers
2020 Scotto L.; Kinahan C.; Casadei B.; Mangone M.; Douglass E.; Murty V.V.; Marchi E.; Ma H.; George C.; Montanari F.; Califano A.; O'Connor O.A.
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience
2020 Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Cavo M.; Zinzani P.L.
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report
2021 Lolli G.; Casadei B.; Argnani L.; Pileri A.; Pellegrini C.; Zinzani P.L.
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas
2021 Bonifazi F.; Defrancesco I.; Olivieri J.; Barbato F.; Lopedote P.; Dicataldo M.; Sessa M.; Dan E.; Sinigaglia B.; Zazzeroni L.; Rizzi S.; Tassi C.; Casadei B.; Zinzani P.L.; Arpinati M.
Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report
2021 Lolli G.; Casadei B.; Pellegrini C.; Argnani L.; Cocito F.; Zinzani P.L.
Long-term efficacy and safety of ibrutinib in the treatment of CLL patients: A real life experience
2021 Broccoli A.; Argnani L.; Morigi A.; Nanni L.; Casadei B.; Pellegrini C.; Stefoni V.; Zinzani P.L.
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi
2021 Ballotta L.; Zinzani P.L.; Pileri S.; Bruna R.; Tani M.; Casadei B.; Tabanelli V.; Volpetti S.; Luminari S.; Corradini P.; Lucchini E.; Tisi M.C.; Merli M.; Re A.; Varettoni M.; Pesce E.A.; Zaja F.
Gut Microbiota Role in Response to Checkpoint Inhibitor Treatment in Patients with Relapsed/Refractory B-Cell Hodgkin Lymphoma: The MICRO-Linf Study
2021 Casadei, B; Guadagnuolo, S; Barone, M; Turroni, S; Argnani, L; Brigidi, P; Zinzani, PL
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients
2021 Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Cavo M.; Zinzani P.L.
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience
2021 Broccoli A.; Argnani L.; Nanni L.; Terragna C.; Sabattini E.; Gabrielli G.; Stefoni V.; Pellegrini C.; Casadei B.; Morigi A.; Lolli G.; Carella M.; Coppola P.E.; Zinzani P.L.
Rapid but reversible progression and transformation of chronic lymphocytic leukemia after temporary ibrutinib discontinuation due to off-target toxicity: two interesting cases
2021 Coppola P.E.; Broccoli A.; Argnani L.; Casadei B.; Stefoni V.; Bertuzzi C.; Sabattini E.; Zinzani P.L.
Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides)
2021 Pileri, Alessandro; Guglielmo, Alba; Patrizi, Annalisa; Casadei, Beatrice; Bertuzzi, Clara; Zinzani, Pier Luigi; Agostinelli, Claudio
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
2021 Merryman R.W.; Castagna L.; Giordano L.; Ho V.T.; Corradini P.; Guidetti A.; Casadei B.; Bond D.A.; Jaglowski S.; Spinner M.A.; Arai S.; Lowsky R.; Shah G.L.; Perales M.-A.; De Colella J.M.S.; Blaise D.; Herrera A.F.; Shouse G.; Spilleboudt C.; Ansell S.M.; Nieto Y.; Badar T.; Hamadani M.; Feldman T.A.; Dahncke L.; Singh A.K.; McGuirk J.P.; Nishihori T.; Chavez J.; Serritella A.V.; Kline J.; Mohty M.; Dulery R.; Stamatoulas A.; Houot R.; Manson G.; Moles-Moreau M.-P.; Orvain C.; Bouabdallah K.; Modi D.; Ramchandren R.; Lekakis L.; Beitinjaneh A.; Frigault M.J.; Chen Y.-B.; Lynch R.C.; Smith S.D.; Rao U.; Byrne M.; Romancik J.T.; Cohen J.B.; Nathan S.; Phillips T.; Joyce R.M.; Rahimian M.; Bashey A.; Ballard H.J.; Svoboda J.; Torri V.; Sollini M.; De Philippis C.; Magagnoli M.; Santoro A.; Armand P.; Zinzani P.L.; Carlo-Stella C.
Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides)
2021 Pileri A.; Guglielmo A.; Patrizi A.; Casadei B.; Bertuzzi C.; Zinzani P.L.; Agostinelli C.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients | Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; ...Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L. | 2020-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Impressive continuous complete response after mogamulizumab in a heavily pretreated Sézary syndrome patient | Lolli G.; Casadei B.; Argnani L.; Nanni L.; Cavo M.; Zinzani P.L. | 2020-01-01 | MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | - | 1.01 Articolo in rivista | mjhid-12-1-e2020040.pdf |
| (90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study | Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi..., Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L | 2020-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | Br J Haematol - 2020 - Lolli - 90Y‐ibritumomab tiuxetan in patients with extra‐nodal marginal zone B‐cell lymphoma of.pdf |
| Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma | Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Co...ppola P.E.; Carella M.; Cavo M.; Zinzani P.L. | 2020-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | cam4.3262.pdf |
| Elderly Non-GCB Diffuse Large B-Cell Lymphoma Patient Responding to Lenalidomide after Epicardial Relapse: A Case Report | Gentilini M.; Casadei B.; Broccoli A.; Argnani L.; Cavo M.; Zinzani P.L. | 2020-01-01 | ACTA HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report | Marangon M.; Casadei B.; Broccoli A.; Argnani L.; Cavo M.; Zinzani P.L. | 2020-01-01 | CLINICAL CASE REPORTS | - | 1.01 Articolo in rivista | CCR3-8-933.pdf |
| Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers | Scotto L.; Kinahan C.; Casadei B.; Mangone M.; Douglass E.; Murty V.V.; Marchi E.; Ma H.; George ...C.; Montanari F.; Califano A.; O'Connor O.A. | 2020-01-01 | GENES, CHROMOSOMES & CANCER | - | 1.01 Articolo in rivista | Genes Chromosomes Cancer - 2020 - Scotto - Generation of pralatrexate resistant T‐cell lymphoma lines reveals two.pdf; GCC-59-639-s004.zip |
| Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience | Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Co...ppola P.E.; Carella M.; Cavo M.; Zinzani P.L. | 2020-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report | Lolli G.; Casadei B.; Argnani L.; Pileri A.; Pellegrini C.; Zinzani P.L. | 2021-01-01 | ACTA HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas | Bonifazi F.; Defrancesco I.; Olivieri J.; Barbato F.; Lopedote P.; Dicataldo M.; Sessa M.; Dan E....; Sinigaglia B.; Zazzeroni L.; Rizzi S.; Tassi C.; Casadei B.; Zinzani P.L.; Arpinati M. | 2021-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report | Lolli G.; Casadei B.; Pellegrini C.; Argnani L.; Cocito F.; Zinzani P.L. | 2021-01-01 | TUMORI | - | 1.01 Articolo in rivista | - |
| Long-term efficacy and safety of ibrutinib in the treatment of CLL patients: A real life experience | Broccoli A.; Argnani L.; Morigi A.; Nanni L.; Casadei B.; Pellegrini C.; Stefoni V.; Zinzani P.L. | 2021-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-10-05845-v2.pdf |
| Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi | Ballotta L.; Zinzani P.L.; Pileri S.; Bruna R.; Tani M.; Casadei B.; Tabanelli V.; Volpetti S.; L...uminari S.; Corradini P.; Lucchini E.; Tisi M.C.; Merli M.; Re A.; Varettoni M.; Pesce E.A.; Zaja F. | 2021-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-11-789891.pdf |
| Gut Microbiota Role in Response to Checkpoint Inhibitor Treatment in Patients with Relapsed/Refractory B-Cell Hodgkin Lymphoma: The MICRO-Linf Study | Casadei, B; Guadagnuolo, S; Barone, M; Turroni, S; Argnani, L; Brigidi, P; Zinzani, PL | 2021-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
| Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients | Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Co...ppola P.E.; Carella M.; Cavo M.; Zinzani P.L. | 2021-01-01 | ANNALS OF HEMATOLOGY | - | 1.01 Articolo in rivista | s00277-020-04364-0.pdf |
| The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience | Broccoli A.; Argnani L.; Nanni L.; Terragna C.; Sabattini E.; Gabrielli G.; Stefoni V.; Pellegrin...i C.; Casadei B.; Morigi A.; Lolli G.; Carella M.; Coppola P.E.; Zinzani P.L. | 2021-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Rapid but reversible progression and transformation of chronic lymphocytic leukemia after temporary ibrutinib discontinuation due to off-target toxicity: two interesting cases | Coppola P.E.; Broccoli A.; Argnani L.; Casadei B.; Stefoni V.; Bertuzzi C.; Sabattini E.; Zinzani... P.L. | 2021-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides) | Pileri, Alessandro; Guglielmo, Alba; Patrizi, Annalisa; Casadei, Beatrice; Bertuzzi, Clara; Zinza...ni, Pier Luigi; Agostinelli, Claudio | 2021-01-01 | JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | - | 1.01 Articolo in rivista | - |
| Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma | Merryman R.W.; Castagna L.; Giordano L.; Ho V.T.; Corradini P.; Guidetti A.; Casadei B.; Bond D.A....; Jaglowski S.; Spinner M.A.; Arai S.; Lowsky R.; Shah G.L.; Perales M.-A.; De Colella J.M.S.; Blaise D.; Herrera A.F.; Shouse G.; Spilleboudt C.; Ansell S.M.; Nieto Y.; Badar T.; Hamadani M.; Feldman T.A.; Dahncke L.; Singh A.K.; McGuirk J.P.; Nishihori T.; Chavez J.; Serritella A.V.; Kline J.; Mohty M.; Dulery R.; Stamatoulas A.; Houot R.; Manson G.; Moles-Moreau M.-P.; Orvain C.; Bouabdallah K.; Modi D.; Ramchandren R.; Lekakis L.; Beitinjaneh A.; Frigault M.J.; Chen Y.-B.; Lynch R.C.; Smith S.D.; Rao U.; Byrne M.; Romancik J.T.; Cohen J.B.; Nathan S.; Phillips T.; Joyce R.M.; Rahimian M.; Bashey A.; Ballard H.J.; Svoboda J.; Torri V.; Sollini M.; De Philippis C.; Magagnoli M.; Santoro A.; Armand P.; Zinzani P.L.; Carlo-Stella C. | 2021-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) | Pileri A.; Guglielmo A.; Patrizi A.; Casadei B.; Bertuzzi C.; Zinzani P.L.; Agostinelli C. | 2021-01-01 | JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile